The Trump administration's proposal to lower drug prices focuses on discounts. A health policy scholar argues that the US could learn from Europe's system of measuring drug value and effectiveness.
Shortages and high prices are making pharmaceuticals, often including generics, out of reach for millions of Americans.
The rising costs of generic drugs have led to outcries. In a search for solutions, four hospital systems are proposing to make drugs on their own. Could their idea work?